179 related articles for article (PubMed ID: 22920049)
1. How do compliance, convenience, and tolerability affect blood pressure goal rates?
Erdine S
Am J Cardiovasc Drugs; 2012 Oct; 12(5):295-302. PubMed ID: 22920049
[TBL] [Abstract][Full Text] [Related]
2. [On the way to achieve hypertension treatment goals: results of the open observational program AESCULAP (exforge--clinical safety and efficiency of using a double combination of antihypertensive drugs in patients with uncontrolled blood pressure)].
Chazova IE; Martynyuk TV
Ter Arkh; 2013; 85(9):35-45. PubMed ID: 24261228
[TBL] [Abstract][Full Text] [Related]
3. Fixed-Dose Triple Combination of Antihypertensive Drugs Improves Blood Pressure Control: From Clinical Trials to Clinical Practice.
Mazza A; Lenti S; Schiavon L; Sacco AP; Dell'Avvocata F; Rigatelli G; Ramazzina E
Adv Ther; 2017 Apr; 34(4):975-985. PubMed ID: 28299716
[TBL] [Abstract][Full Text] [Related]
4. Personalised Single-Pill Combination Therapy in Hypertensive Patients: An Update of a Practical Treatment Platform.
Volpe M; Tocci G; de la Sierra A; Kreutz R; Laurent S; Manolis AJ; Tsioufis K
High Blood Press Cardiovasc Prev; 2017 Dec; 24(4):463-472. PubMed ID: 29086364
[TBL] [Abstract][Full Text] [Related]
5. Optimizing the Management of Uncontrolled Hypertension: What do Triple Fixed-Dose Drug Combinations Add?
Thomopoulos C; Katsimagklis G; Archontakis S; Skalis G; Makris T
Curr Vasc Pharmacol; 2017; 16(1):61-65. PubMed ID: 28413969
[TBL] [Abstract][Full Text] [Related]
6. Improving treatment adherence to antihypertensive therapy: the role of single-pill combinations.
Bangalore S; Ley L
Expert Opin Pharmacother; 2012 Feb; 13(3):345-55. PubMed ID: 22220825
[TBL] [Abstract][Full Text] [Related]
7. Optimizing blood pressure control through the use of fixed combinations.
Düsing R
Vasc Health Risk Manag; 2010 May; 6():321-5. PubMed ID: 20531950
[TBL] [Abstract][Full Text] [Related]
8. Management of hypertension with fixed-dose triple-combination treatments.
Epstein BJ; Shah NK; Borja-Hart NL
Ther Adv Cardiovasc Dis; 2013 Oct; 7(5):246-59. PubMed ID: 23945906
[TBL] [Abstract][Full Text] [Related]
9. A role for single-pill triple therapy in hypertension.
Elijovich F; Laffer C
Ther Adv Cardiovasc Dis; 2009 Jun; 3(3):231-40. PubMed ID: 19443512
[TBL] [Abstract][Full Text] [Related]
10. Triple Combination Therapies Based on Olmesartan: A Personalized Therapeutic Approach to Improve Blood Pressure Control.
Volpe M; Santolamazza C; Mastromarino V; Coluccia R; Battistoni A; Tocci G
High Blood Press Cardiovasc Prev; 2017 Sep; 24(3):255-263. PubMed ID: 28608025
[TBL] [Abstract][Full Text] [Related]
11. Single-Pill Triple Fixed Dose Combination Therapy with Single Component Drug Monitoring in Treatment-Resistant Hypertension: A Pilot Study.
Kreutz R; Scholze J; Douros A
Curr Vasc Pharmacol; 2018 Jan; 16(2):197-203. PubMed ID: 28828980
[TBL] [Abstract][Full Text] [Related]
12. Using fixed-dose combination therapies to achieve blood pressure goals.
Chrysant SG
Clin Drug Investig; 2008; 28(11):713-34. PubMed ID: 18840014
[TBL] [Abstract][Full Text] [Related]
13. Impact of antihypertensive medication adherence on blood pressure control in hypertension: the COMFORT study.
Matsumura K; Arima H; Tominaga M; Ohtsubo T; Sasaguri T; Fujii K; Fukuhara M; Uezono K; Morinaga Y; Ohta Y; Otonari T; Kawasaki J; Kato I; Tsuchihashi T;
QJM; 2013 Oct; 106(10):909-14. PubMed ID: 23696676
[TBL] [Abstract][Full Text] [Related]
14. Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients.
Neutel JM
Curr Med Res Opin; 2008 Aug; 24(8):2389-401. PubMed ID: 18616863
[TBL] [Abstract][Full Text] [Related]
15. Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats.
Sica DA
Drugs; 2002; 62(3):443-62. PubMed ID: 11827559
[TBL] [Abstract][Full Text] [Related]
16. Long-term blood pressure control: what can we do?
Neutel JM
Postgrad Med; 2011 Jan; 123(1):88-93. PubMed ID: 21293088
[TBL] [Abstract][Full Text] [Related]
17. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
Roberts ME; Epstein BJ
J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098
[TBL] [Abstract][Full Text] [Related]
18. Triple-combination therapy in the treatment of hypertension: a review of the evidence.
Düsing R; Waeber B; Destro M; Santos Maia C; Brunel P
J Hum Hypertens; 2017 Aug; 31(8):501-510. PubMed ID: 28230062
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes in hypertensive patients treated with a single-pill fixed-dose combination of renin-angiotensin system inhibitor and thiazide diuretic.
Ho CT; Tung YC; Chou SH; Hsiao FC; Lin YS; Chang CJ; Chu PH
J Clin Hypertens (Greenwich); 2018 Dec; 20(12):1731-1738. PubMed ID: 30375168
[TBL] [Abstract][Full Text] [Related]
20. Hypertension management: rationale for triple therapy based on mechanisms of action.
Neutel JM; Smith DH
Cardiovasc Ther; 2013 Oct; 31(5):251-8. PubMed ID: 23121769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
